Atricure Inc. buy Needham & Company LLC
Start price
03.11.23
/
50%
€35.20
Target price
03.11.24
€45.71
Performance (%)
-
End price
04.11.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Atricure Inc. | 8.434% | 8.434% | -41.935% |
| iShares Core DAX® | 2.331% | 5.140% | 25.000% |
| iShares Nasdaq 100 | 2.077% | 2.956% | 8.935% |
| iShares Nikkei 225® | 2.759% | 7.214% | 22.171% |
| iShares S&P 500 | 1.613% | 2.893% | 6.249% |
Comments by Needham___Company_LL for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its price target lowered by analysts at Needham & Company LLC from $68.00 to $49.00. They now have a "buy" rating on the stock.
Ratings data for ATRC provided by MarketBeat
In the thread Trading Atricure Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten